(Q43263268)

English

Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence

scientific article published in November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Richard A. Larson

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Koen van Besien

object named as

Koen van Besien

1

0 references

author name string

Alexander Dew

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Shang Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Loren Joseph

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Lucy A Godley

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Toyosi Odenike

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Elizabeth Rich

8

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Wendy Stock

9

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Amittha Wickrema

10

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Andrew S Artz

11

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1809-1817

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Mixed chimerism: preclinical studies and clinical applications

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Choice and interpretation of statistical tests used when competing risks are present

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-fr

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

1 reference

https://api.crossref.org/works/10.3109%2F10428190903200790

21 January 2018

Identifiers

10.3109/10428190903200790

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43263268&oldid=1985086164"